Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Jeffrey S Gilbert"'
Autor:
Jean F Regal, Kathryn E Lillegard, Ashley J Bauer, Barbara J Elmquist, Alex C Loeks-Johnson, Jeffrey S Gilbert
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132063 (2015)
Preeclampsia is characterized by reduced placental perfusion with placental ischemia and hypertension during pregnancy. Preeclamptic women also exhibit a heightened inflammatory state and greater number of neutrophils in the vasculature compared to n
Externí odkaz:
https://doaj.org/article/d6e133cc1279460e8701eef7aabe44dc
Autor:
Kendra J. Towner, Cameron R. Wing, Sherry D. Fleming, Connor F. Laule, Kate M. Root, Jean F. Regal, Evan Odean, Jeffrey S. Gilbert, Cassandra M Hamm
Publikováno v:
Am J Physiol Heart Circ Physiol
Preeclampsia is a prevalent pregnancy complication characterized by new-onset maternal hypertension and inflammation, with placental ischemia as the initiating event. Studies of others have provided evidence for the importance of lymphocytes in place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1489691c766bc86036e85c77cc94d80
https://doi.org/10.1152/ajpheart.00132.2019
https://doi.org/10.1152/ajpheart.00132.2019
Publikováno v:
Am J Physiol Heart Circ Physiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c3fe74cac6174c2d04ea817d54f2158
https://pubmed.ncbi.nlm.nih.gov/32141769
https://pubmed.ncbi.nlm.nih.gov/32141769
Autor:
Connor F. Laule, Jean F. Regal, Evan Odean, Cameron R. Wing, Jeffrey S. Gilbert, Jacob A Wilcox
Publikováno v:
Journal of Immunotoxicology, Vol 14, Iss 1, Pp 235-240 (2017)
Preeclampsia is a pregnancy-specific condition manifested by new-onset maternal hypertension with systemic inflammation, including increased innate immune system complement activation. While exact pathophysiology is unknown, evidence suggests that in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f5dc1f1521809aaced0e393875a589
https://doi.org/10.1080/1547691x.2017.1394934
https://doi.org/10.1080/1547691x.2017.1394934
Autor:
Lynne T. Bemis, Sherry D. Fleming, Kate M. Root, Cameron R. Wing, Jenna M. Lund, Jean F. Regal, Jeffrey S. Gilbert, Luke McCutcheon
Publikováno v:
Mol Immunol
Preeclampsia is characterized by new onset hypertension and fetal growth restriction and is associated with aberrant activation of the innate immune complement system and stressed or ischemic placenta. Previous studies have suggested a role for both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497c03a87942eccef29e7cc338fb6fef
https://pubmed.ncbi.nlm.nih.gov/31326653
https://pubmed.ncbi.nlm.nih.gov/31326653
Autor:
Jeffrey S. Gilbert, Noel Fernando Nieto, Jean F. Regal, Megan E. Strehlke, Cameron R. Wing, Jenna M. Peterson, Lynne T. Bemis, Sherry D. Fleming, Jordan E. Parker
Publikováno v:
Molecular Immunology. 78:38-47
Preeclampsia is characterized by development of hypertension during pregnancy and reduced placental perfusion. Previous studies in a rat model of placental ischemia-induced hypertension demonstrated that inhibiting complement activation attenuated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1096941167364547590ed8fb0bd606e4
https://doi.org/10.1016/j.molimm.2016.08.016
https://doi.org/10.1016/j.molimm.2016.08.016
Autor:
Evan Odean, Sherry D. Fleming, Jeffrey S. Gilbert, Cameron R. Wing, Connor F. Laule, Jean F. Regal
Publikováno v:
The FASEB Journal. 32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b282406abcb83923c472de0f7d9c8d8
https://doi.org/10.1096/fasebj.2018.32.1_supplement.729.4
https://doi.org/10.1096/fasebj.2018.32.1_supplement.729.4
Publikováno v:
Hypertension. 70
Preeclampsia is characterized by hypertension, reduced placental perfusion, intrauterine growth restriction and increased activation of complement, part of innate immunity. Using the Reduced Uterine Perfusion Pressure (RUPP) model of placental ischem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76dd9a5f236dfdb785a66e076e5706fd
https://doi.org/10.1161/hyp.70.suppl_1.p303
https://doi.org/10.1161/hyp.70.suppl_1.p303
Autor:
Ashley J. Bauer, Ronald R. Regal, Jenna M. Peterson, Jeffrey S. Gilbert, Jean F. Regal, Jonathan W. Opacich, Alex C. Loeks-Johnson, Kathryn E Lillegard, Barbara J. Elmquist
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 351:344-351
Early-onset pre-eclampsia is characterized by decreased placental perfusion, new-onset hypertension, angiogenic imbalance, and endothelial dysfunction associated with excessive activation of the innate immune complement system. Although our previous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c8b72065d74861481803de6ea5092cf
https://doi.org/10.1124/jpet.114.218123
https://doi.org/10.1124/jpet.114.218123
Autor:
Henry Marsh, Sarah J. Lojovich, Ashley J. Bauer, Alex C. Johnson, Jeffrey S. Gilbert, Kathryn E Lillegard, Jean F. Regal
Publikováno v:
Molecular Immunology. 56:91-97
Preeclampsia is a major obstetric problem defined by new-onset hypertension and proteinuria associated with compromised placental perfusion. Although activation of the complement system is increased in preeclampsia compared to normal pregnancy, it re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d331098ad56d8c6520313de194a3ec
https://doi.org/10.1016/j.molimm.2013.04.009
https://doi.org/10.1016/j.molimm.2013.04.009